Han Jia Lin
Director/Board Member at GLAC BIOTECH CO., LTD.
Network origin in Han Jia Lin first degree
Entity | Entity type | Industry | |
---|---|---|---|
Private Company | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Han Jia Lin via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Bioengine Capital, Inc.
Bioengine Capital, Inc. BiotechnologyHealth Technology Part of Center Laboratories, Inc., Bioengine Capital, Inc. is a Taiwanese company that focuses on investment, biotechnology, and research and development. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
LUMOSA THERAPEUTICS CO., LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
CENTER LABORATORIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chairman | |
Yusheng Venture Capital Co. Ltd.
Yusheng Venture Capital Co. Ltd. Investment ManagersFinance Part of Center Laboratories, Inc., Yusheng Venture Capital Co. Ltd. is an alternative investment manager. | Investment Managers | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Tot Biopharm Co. Ltd.
Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Anhui Jinlac Biotech Ltd. | Director/Board Member Chairman Director/Board Member | ||
GLORY BIOTECH CO LTD | Biotechnology | Chairman Director/Board Member Director/Board Member | |
National Taiwan University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
Glac & George Biotech Co. Ltd. (Anhui) | Director/Board Member Chairman | ||
TSH BIOPHARM CORPORATION LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MYCENAX BIOTECH INC. | Biotechnology | Director/Board Member Chairman | |
National Chengchi University | College/University | Graduate Degree Graduate Degree | |
Yucheng Management Consultant Co. Ltd. | Investment Managers | Director/Board Member Chairman | |
PHARMAENGINE, INC. | Pharmaceuticals: Major | Founder Investor Relations Contact | |
MEDEON BIODESIGN, INC. | Electronic Equipment/Instruments | Chairman Director/Board Member | |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Founder | |
Univision Pharmaceutical Co., Ltd. | Chairman Director/Board Member | ||
TTY BIOPHARM COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
MEM DENTAL TECHNOLOGY CO., LTD. | Medical Specialties | Director/Board Member | |
Chengdu Shuyu Pharmaceutical Co. Ltd.
Chengdu Shuyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of TTY Biopharm Co. Ltd., Chengdu Shuyu Pharmaceutical Co. Ltd. is a company that manufactures and distributes pharmaceutical products. The company is based in Chengdu, China. Chengdu Shuyu Pharmaceutical Co. was acquired by Worldco International Co. Ltd. on October 26, 2012 for $0.51 million. | Pharmaceuticals: Major | Chairman | |
Medeon International, Inc. | Director/Board Member | ||
AUSNUTRIA DAIRY CORPORATION LTD | Food: Major Diversified | Director/Board Member | |
Pharmacenter International Co., Ltd. | Chairman | ||
Centerlab Investmnent Holding Ltd.
Centerlab Investmnent Holding Ltd. Financial ConglomeratesFinance Part of Center Laboratories, Inc., Centerlab Investment Holding Ltd. is based in Hong Kong, Hong Kong. The Chinese company functions as an investment holding company. | Financial Conglomerates | Chairman | |
M-VENTURE INVESTMENT, INC. | Investment Managers | Director/Board Member | |
Medeon, Inc. | Director/Board Member | ||
IXENSOR CO., LTD. | Medical Specialties | Director/Board Member | |
CROWN BIOSCIENCE INTERNATIONAL | Biotechnology | Director/Board Member | |
Epitomics International, Inc. | Director/Board Member | ||
JLC Biotech Holding Ltd. | Director/Board Member | ||
POWERTECH TECHNOLOGY INC. | Semiconductors | Director/Board Member | |
Taipei Medical University | College/University | Doctorate Degree | |
Transpacific Medtech Fund L P | Corporate Officer/Principal | ||
Changzhou Olong Electrical Insulation Materials Co., Ltd.
Changzhou Olong Electrical Insulation Materials Co., Ltd. Other Metals/MineralsNon-Energy Minerals Changzhou Olong Electrical Insulation Materials Co., Ltd. is a Sino-foreign JV enterprise founded by Changzhou Electrical Insulation Main Works Co., Ltd., China and Isovolta AG, Austria. The main products are PU, MPE, PEl, PAI and so on. Most of the products are UL listed already. The main production technologies are provided by the foreign partner, the laboratories setted by both sides provide the technology support long-term. In order to satisfy the different requirements of the Chinese customers constantly, the foreign side has appointed several technologists to work in Changzhou Olong all the year round. Changzhou Olong has the excellent manufacturing equipments and advanced control equipments, including two enameling machines (one is vertical, the other is horizontal, all of which are produced by Germany), one testing machine for tg d, and all the other testing equipments for the enameled wire. So it can study the technology of the enameled wire independently. The annual production capability of the company is more than 10000 tons. 'Honest, realistic approach, innovation and sharing win' is the company's persistent management value. It persistently treats the men as the base and the market as the center, and shall make 'CHANGZHOU OLONG' brand perfect consistently. There will be a totally new 'CHANGZHOU OLONG' in Changzhou Developing area in the next two or three years, and the whole designing plan for the new company will be provided by a foreign specialized company, the annual production capability will be 20,000 tons. | Other Metals/Minerals | Chairman | |
ADIMMUNE CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
BIOGEND THERAPEUTICS CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Chinese Culture University | College/University | Undergraduate Degree | |
Xudong Haipu International Co. Ltd. | Director/Board Member | ||
EVER FORTUNE.AI CO., LTD. | Packaged Software | Director/Board Member | |
National Yang Ming University | College/University | Graduate Degree | |
Soochow University /Taiwan/ | College/University | Graduate Degree | |
National Chung Hsing University | College/University | Doctorate Degree | |
Chung Shan Medical University | College/University | Graduate Degree | |
Shih Chien University | College/University | Undergraduate Degree | |
San Francisco State University | College/University | Graduate Degree | |
Tunghai University | College/University | Undergraduate Degree | |
Shanghai Xudong Haipu Jiading Pharmaceutical Co. | Director/Board Member | ||
Tongshin Pharmaceutical Co. Ltd. | President | ||
Glac & George Biotech Co., Ltd. | Director/Board Member |
Statistics
International
Taiwan | 32 |
China | 9 |
Hong Kong | 6 |
Cayman Islands | 4 |
South Korea | 2 |
Sectoral
Health Technology | 17 |
Consumer Services | 12 |
Finance | 5 |
Electronic Technology | 3 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 79 |
Chairman | 34 |
Undergraduate Degree | 8 |
Graduate Degree | 7 |
President | 5 |
Most connected contacts
Insiders | |
---|---|
Jung Chin Lin | 49 |
Wan Lai Cheng | 24 |
Chung Liang Li | 20 |
Su Chi Wang | 11 |
Chung Wei Kuo | 5 |
Pei Shan Hsieh | 4 |
Sheng Hung Huang | 4 |
Chi Hsing Chang | 3 |
Zhong Chuan Shi | 3 |
Shang E Tseng | 1 |
- Stock Market
- Insiders
- Han Jia Lin
- Company connections